Computational drug design applied to the study of metabotropic glutamate receptors

Claudia Llinas del Torrent, Laura Pérez-Benito, Gary Tresadern

    Producció científica: Contribució a revistaArticle de revisióRecercaAvaluat per experts

    11 Cites (Scopus)

    Resum

    © 2019 by the authors. Metabotropic glutamate (mGlu) receptors are a family of eight GPCRs that are attractive drug discovery targets to modulate glutamate action and response. Here we review the application of computational methods to the study of this family of receptors. X-ray structures of the extracellular and 7-transmembrane domains have played an important role to enable structure-based modeling approaches, whilst we also discuss the successful application of ligand-based methods. We summarize the literature and highlight the areas where modeling and experiment have delivered important understanding for mGlu receptor drug discovery. Finally, we offer suggestions of future areas of opportunity for computational work.
    Idioma originalAnglès
    Número d’article1098
    RevistaMolecules
    Volum24
    Número6
    DOIs
    Estat de la publicacióPublicada - 20 de març 2019

    Fingerprint

    Navegar pels temes de recerca de 'Computational drug design applied to the study of metabotropic glutamate receptors'. Junts formen un fingerprint únic.

    Com citar-ho